In Finland, the pharmaceutical industry has great potential for development, according to Marco Hautalahti of FINBB. However, there are concerns that the government’s austerity measures could hinder the competitive advantage of the industry.
Marco Hautalahti, CEO of FINBB, recently returned from a business trip to Boston, USA and shared his insights on the potential of the pharmaceutical industry in Finland. Despite the time zone difference, he emphasized on ensuring that the industry continues to thrive and innovate without being hindered by government policies.
In Denmark, the pharmaceutical industry plays a significant role in boosting the national economy, with Novo Nordisk leading the way. It is important for government policies to support the growth and innovation of the industry to ensure long-term success. Marco Hautalahti’s insights shed light on the opportunities and challenges facing the pharmaceutical industry in Finland.
